105 related articles for article (PubMed ID: 7507148)
1. The effect of alpha 2 macroglobulin in commercial cytokine assays.
James K; Milne I; Cunningham A; Elliott SF
J Immunol Methods; 1994 Jan; 168(1):33-7. PubMed ID: 7507148
[TBL] [Abstract][Full Text] [Related]
2. Variable estimates of cytokine levels produced by commercial ELISA kits: results using international cytokine standards.
Ledur A; Fitting C; David B; Hamberger C; Cavaillon JM
J Immunol Methods; 1995 Oct; 186(2):171-9. PubMed ID: 7594617
[TBL] [Abstract][Full Text] [Related]
3. Activated alpha 2-macroglobulin reverses the immunosuppressive activity in human breast cancer cell-conditioned medium by selectively neutralizing transforming growth factor-beta in the presence of interleukin-2.
Harthun NL; Weaver AM; Brinckerhoff LH; Deacon DH; Gonias SL; Slingluff CL
J Immunother; 1998 Mar; 21(2):85-94. PubMed ID: 9551359
[TBL] [Abstract][Full Text] [Related]
4. Cytokine binding and clearance properties of proteinase-activated alpha 2-macroglobulins.
LaMarre J; Wollenberg GK; Gonias SL; Hayes MA
Lab Invest; 1991 Jul; 65(1):3-14. PubMed ID: 1712874
[TBL] [Abstract][Full Text] [Related]
5. Binding of IL-1 beta to alpha-macroglobulins and release by thioredoxin.
Borth W; Scheer B; Urbansky A; Luger TA; Sottrup-Jensen L
J Immunol; 1990 Dec; 145(11):3747-54. PubMed ID: 1700994
[TBL] [Abstract][Full Text] [Related]
6. Interaction of transforming growth factor-beta-1 with alpha-2-macroglobulin from normal and inflamed equine joints.
Coté N; Trout DR; Hayes MA
Can J Vet Res; 1998 Oct; 62(4):279-86. PubMed ID: 9798094
[TBL] [Abstract][Full Text] [Related]
7. Enzyme-linked immunosorbent assay (ELISA) for the measurement of small quantities of alpha 2-macroglobulin.
Munck Petersen C; Vestergård Povlsen J; Ingerslev J
Scand J Clin Lab Invest; 1985 Dec; 45(8):735-40. PubMed ID: 2417304
[TBL] [Abstract][Full Text] [Related]
8. ELISA assays and alcohol: increasing carbon chain length can interfere with detection of cytokines.
von Maltzan K; Pruett SB
Alcohol; 2011 Feb; 45(1):1-9. PubMed ID: 20843633
[TBL] [Abstract][Full Text] [Related]
9. Studies on the interaction of IL-8 with human plasma alpha 2-macroglobulin: evidence for the presence of IL-8 complexed to alpha 2-macroglobulin in lung fluids of patients with adult respiratory distress syndrome.
Kurdowska A; Carr FK; Stevens MD; Baughman RP; Martin TR
J Immunol; 1997 Feb; 158(4):1930-40. PubMed ID: 9029135
[TBL] [Abstract][Full Text] [Related]
10. Binding of platelet-derived growth factor-BB and transforming growth factor-beta 1 to alpha 2-macroglobulin in vitro and in vivo: comparison of receptor-recognized and non-recognized alpha 2-macroglobulin conformations.
Crookston KP; Webb DJ; Lamarre J; Gonias SL
Biochem J; 1993 Jul; 293 ( Pt 2)(Pt 2):443-50. PubMed ID: 7688216
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of accuracy and uncertainty of ELISA assays for the determination of interleukin-4, interleukin-5, interferon-gamma and tumor necrosis factor-alpha.
Borg L; Kristiansen J; Christensen JM; Jepsen KF; Poulsen LK
Clin Chem Lab Med; 2002 May; 40(5):509-19. PubMed ID: 12113298
[TBL] [Abstract][Full Text] [Related]
12. Improved sensitivity of colorimetric compared to chemiluminescence ELISAs for cytokine assays.
Siddiqui J; Remick DG
J Immunoassay Immunochem; 2003; 24(3):273-83. PubMed ID: 12953972
[TBL] [Abstract][Full Text] [Related]
13. Binding of tumor necrosis factor alpha to activated forms of human plasma alpha 2 macroglobulin.
Wollenberg GK; LaMarre J; Rosendal S; Gonias SL; Hayes MA
Am J Pathol; 1991 Feb; 138(2):265-72. PubMed ID: 1704186
[TBL] [Abstract][Full Text] [Related]
14. Binding of transforming growth factor-beta 1 to methylamine-modified alpha 2-macroglobulin and to binary and ternary alpha 2-macroglobulin-proteinase complexes.
Hall SW; LaMarre J; Marshall LB; Hayes MA; Gonias SL
Biochem J; 1992 Jan; 281 ( Pt 2)(Pt 2):569-75. PubMed ID: 1371050
[TBL] [Abstract][Full Text] [Related]
15. Crystallization and preliminary X-ray analysis of methylamine-treated alpha 2-macroglobulin and 3 alpha 2-macroglobulin-proteinase complexes.
Andersen GR; Jacobsen L; Thirup S; Nyborg J; Sottrup-Jensen L
FEBS Lett; 1991 Nov; 292(1-2):267-70. PubMed ID: 1720400
[TBL] [Abstract][Full Text] [Related]
16. Serum alpha2-macroglobulin and cytokine measurements in an acute inflammation model in rats.
Jinbo T; Sakamoto T; Yamamoto S
Lab Anim; 2002 Apr; 36(2):153-7. PubMed ID: 11943079
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of plasma alpha-2-macroglobulin and interactions with tumour necrosis factor-alpha in horses with endotoxemic signs.
Coté N; Trout DR; Hayes AM
Can J Vet Res; 1996 Apr; 60(2):150-7. PubMed ID: 8785722
[TBL] [Abstract][Full Text] [Related]
18. Differences in the binding of transforming growth factor beta 1 to the acute-phase reactant and constitutively synthesized alpha-macroglobulins of rat.
Webb DJ; Crookston KP; Figler NL; Lamarre J; Gonias SL
Biochem J; 1995 Dec; 312 ( Pt 2)(Pt 2):579-86. PubMed ID: 8526873
[TBL] [Abstract][Full Text] [Related]
19. Ligand binding, conformational change and plasma elimination of human, mouse and rat alpha-macroglobulin proteinase inhibitors.
Gonias SL; Balber AE; Hubbard WJ; Pizzo SV
Biochem J; 1983 Jan; 209(1):99-105. PubMed ID: 6189480
[TBL] [Abstract][Full Text] [Related]
20. A modified human alpha 2-macroglobulin derivative that binds tumor necrosis factor-alpha and interleukin-1 beta with high affinity in vitro and reverses lipopolysaccharide toxicity in vivo in mice.
Webb DJ; Gonias SL
Lab Invest; 1998 Aug; 78(8):939-48. PubMed ID: 9714181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
